| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Jun 20, 2024 | CRESCENT BIOPHARMA, INC. | CFO | Buy | 90.0 | +17,500 | 32.93% | ✗ | $4.3K |
| May 17, 2023 | May 18, 2023 | CRESCENT BIOPHARMA, INC. | CFO | Sell | 47.5 | -3,700 | -6.51% | ✗ | $7.2K |
| Nov 11, 2022 | Nov 14, 2022 | CRESCENT BIOPHARMA, INC. | CFO | Buy | 91.3 | +20,000 | 54.28% | ✗ | $21.2K |
| Mar 9, 2022 | Mar 10, 2022 | CRESCENT BIOPHARMA, INC. | CFO | Sell | 47.5 | -2,917 | -7.34% | ✗ | $3.2K |
| Jun 11, 2018 | Jun 12, 2018 | CRESCENT BIOPHARMA, INC. | CFO | Sell | 20.0 | -19,345 | -100.00% | ✗ | $349K |